Literature DB >> 5843865

Agranulocytosis: a report of 30 cases.

H M Pretty, G Gosselin, G Colpron, L A Long.   

Abstract

Thirty cases of acute agranulocytosis, as defined by Schultz, were observed between 1946 and 1964 at the Hôtel-Dieu Hospital, Montreal. In 14 cases agents incriminated were: aminopyrine, phenylbutazone, sulfonamides and chlorpromazine. Aminopyrine alone was responsible for eight cases. In the remaining 16 cases no definite etiology was established. Clinical manifestations included fever, prostration, angina and multiple pharyngeal ulcerations; these were associated with severe leukopenia and agranulocytosis. The bone marrow showed hypoplasia, lymphocytosis and maturation arrest. Localized and pulmonary infections, pseudomembranous enterocolitis and septicemia were frequent complications in 21 cases and were usually responsible for death, which occurred in 12 cases. Almost all patients who developed septicemia or pseudomembranous enterocolitis died. The pathogenesis is still not clear, but chlorpromazine and its analogues may act as a metabolic inhibitor, while the aminopyrine group probably operates through an immune mechanism.

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5843865      PMCID: PMC1936473     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  19 in total

1.  STUDIES ON AGRANULOCYTOSIS. V. PATTERNS OF RECOVERY FROM DRUG-INDUCED BONE MARROW DAMAGE.

Authors:  A V PISCIOTTA; A S SANTOS; C KELLER
Journal:  J Lab Clin Med       Date:  1964-03

2.  Granulocytopenia due to chlorpromazine: a report of 11 cases.

Authors:  S C CARFAGNO; J T MAGEE
Journal:  Am J Med Sci       Date:  1961-01       Impact factor: 2.378

3.  Leukocyte-autoantibodies.

Authors:  S MOESCHLIN
Journal:  Acta Haematol       Date:  1958 Jul-Oct       Impact factor: 2.195

4.  Agranulocytosis due to mepazine (phenothiazine); report of three cases.

Authors:  J M FIORE; F M NOONAN
Journal:  N Engl J Med       Date:  1959-02-19       Impact factor: 91.245

5.  [Prognosis of agranulocytosis and of pancytopenias].

Authors:  G MARCHAL
Journal:  Presse Med       Date:  1959-08-08       Impact factor: 1.228

6.  Fatal agranulocytosis following chlorpropamide treatment of diabetes. Report of a case.

Authors:  H KARLIN
Journal:  N Engl J Med       Date:  1960-05-26       Impact factor: 91.245

7.  [Agranulocytosis due to the occurrence of leukocyte-agglutinins; pyramidon and cold agglutinins].

Authors:  S MOESCHLIN; K WAGNER
Journal:  Acta Haematol       Date:  1952 Jul-Aug       Impact factor: 2.195

8.  Studies on agranulocytosis. IV. Effects of chlorpromazine on nucleic acid synthesis of bone marrow cells in vitro.

Authors:  A V PISCIOTTA; J KALDAHL
Journal:  Blood       Date:  1962-09       Impact factor: 22.113

9.  Agranulocytosis due to imipramine (tofranil).

Authors:  C E BIRD
Journal:  Can Med Assoc J       Date:  1960-05-14       Impact factor: 8.262

10.  Agranulocytosis associated with sulphasalazine ('Salazopyrin') therapy.

Authors:  J L THIRKETTLE; K R GOUGH; A E READ
Journal:  Lancet       Date:  1963-06-29       Impact factor: 79.321

View more
  2 in total

Review 1.  Idiosyncratic drug-induced haematological abnormalities. Incidence, pathogenesis, management and avoidance.

Authors:  W N Patton; S B Duffull
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606

Review 2.  On the possible mechanisms and predictability of clozapine-induced agranulocytosis.

Authors:  A V Pisciotta; S A Konings; L L Ciesemier; C E Cronkite; J A Lieberman
Journal:  Drug Saf       Date:  1992       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.